• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Front Public Health . LAMP-LFD: establishment and evaluation of a new diagnostic platform for SARS-CoV-2 rapid detection

tetano

Editor, Senior Moderator
Front Public Health


. 2026 Mar 24:14:1798338.
doi: 10.3389/fpubh.2026.1798338. eCollection 2026.
LAMP-LFD: establishment and evaluation of a new diagnostic platform for SARS-CoV-2 rapid detection

Qizhi Diao[SUP] 1 2 [/SUP], Sha Tang[SUP] 3 [/SUP], Xin Liu[SUP] 2 [/SUP], Jiajia Li[SUP] 2 [/SUP], Xiangmin Zhou[SUP] 2 [/SUP], Yuanyu Chen[SUP] 2 [/SUP], Qiongyuan Zhang[SUP] #[/SUP][SUP] 4 [/SUP], Fangyu Yang[SUP] #[/SUP][SUP] 4 [/SUP]


Affiliations
Abstract

Background: This study aimed to establish a rapid detection method for SARS-CoV-2 by integrating loop-mediated isothermal amplification (LAMP) with lateral flow dipstick (LFD) technology.
Method: Specific primers targeting the nucleocapsid (N) gene and open reading frame 1ab (ORF1ab) gene of SARS-CoV-2 were designed and labeled with 6-FAM and biotin, respectively. After systematically optimizing key reaction parameters, including primer selection, primer concentration, and LAMP reaction time, the sensitivity, specificity, and clinical applicability of the method were evaluated.
Results: The proposed LAMP-LFD assay enables rapid detection within 30 min with high specificity, accurately identifying the N and ORF1ab genes of SARS-CoV-2 without cross-reactivity with influenza A hemagglutinin gene, influenza B neuraminidase gene, and respiratory syncytial virus M gene. The limit of detection reached 1.892 × 10[SUP]1[/SUP] copies/μL, showing comparable sensitivity to agarose gel electrophoresis and real-time quantitative reverse transcription PCR (RT-qPCR). The results were consistent across different batches of primers and probes, demonstrating good reproducibility. When compared with RT-qPCR using 114 inactivated throat swab samples, the diagnostic agreement rate reached 95.61%.
Discussion: This study provides technical support for the surveillance and control of SARS-CoV-2 infection.

Keywords: SARS-CoV-2; lateral flow dipstick; loop-mediated isothermal amplification; rapid detection; the N gene and The ORF1ab gene.

 
Back
Top